{"d":{"__metadata":{"id":"https://ws.parlament.ch/OData.svc/Subject(ID=54322L,Language='FR')","uri":"https://ws.parlament.ch/OData.svc/Subject(ID=54322L,Language='FR')","type":"itsystems.Pd.DataServices.DataModel.Subject"},"Meetings":{"__metadata":{"id":"https://ws.parlament.ch/OData.svc/Meeting(ID=4520L,Language='FR')","uri":"https://ws.parlament.ch/OData.svc/Meeting(ID=4520L,Language='FR')","type":"itsystems.Pd.DataServices.DataModel.Meeting"},"Sessions":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Meeting(ID=4520L,Language='FR')/Sessions"}},"Subjects":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Meeting(ID=4520L,Language='FR')/Subjects"}},"ID":"4520","Language":"FR","MeetingNumber":10,"IdSession":5111,"SessionNumber":11,"SessionName":"Session d'automne 2021","Council":1,"CouncilName":"Conseil national","CouncilAbbreviation":"CN","Date":"\/Date(1632700800000)\/","Begin":"1430","Modified":"\/Date(1635255403867)\/","LegislativePeriodNumber":51,"PublicationStatus":"final","MeetingOrderText":"Dixi\u00e8me s\u00e9ance","SortOrder":10,"Location":"N"},"SubjectsBusiness":{"results":[{"__metadata":{"id":"https://ws.parlament.ch/OData.svc/SubjectBusiness(BusinessNumber=20217967,IdSubject=54322L,Language='FR')","uri":"https://ws.parlament.ch/OData.svc/SubjectBusiness(BusinessNumber=20217967,IdSubject=54322L,Language='FR')","type":"itsystems.Pd.DataServices.DataModel.SubjectBusiness"},"Subjects":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/SubjectBusiness(BusinessNumber=20217967,IdSubject=54322L,Language='FR')/Subjects"}},"Businesses":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/SubjectBusiness(BusinessNumber=20217967,IdSubject=54322L,Language='FR')/Businesses"}},"IdSubject":"54322","BusinessNumber":20217967,"Language":"FR","BusinessShortNumber":"21.7967","Title":"A quelle \u00e9ch\u00e9ance seront \u00e9valu\u00e9s les effets endocriniens des substances actives actuellement autoris\u00e9es en Suisse ?","SortOrder":1,"PublishedNotes":null,"Modified":"\/Date(1632565834910)\/","TitleDE":"Fragestunde. Frage\nPasquier-Eichenberger Isabelle.\nBis wann wird die endokrine Wirkung\nder heute in der Schweiz zugelassenen\nWirkstoffe \u00fcberpr\u00fcft sein?","TitleFR":"Heure des questions. Question\nPasquier-Eichenberger Isabelle.\nA quelle \u00e9ch\u00e9ance seront \u00e9valu\u00e9s\nles effets endocriniens\ndes substances actives\nactuellement autoris\u00e9es en Suisse?","TitleIT":null}]},"Transcripts":{"results":[{"__metadata":{"id":"https://ws.parlament.ch/OData.svc/Transcript(ID=288925L,Language='FR')","uri":"https://ws.parlament.ch/OData.svc/Transcript(ID=288925L,Language='FR')","type":"itsystems.Pd.DataServices.DataModel.Transcript"},"Subjects":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Transcript(ID=288925L,Language='FR')/Subjects"}},"MembersCouncil":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Transcript(ID=288925L,Language='FR')/MembersCouncil"}},"Businesses":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Transcript(ID=288925L,Language='FR')/Businesses"}},"ID":"288925","Language":"FR","IdSubject":"54322","VoteId":null,"PersonNumber":1108,"Type":1,"Text":"<pd_text><p>Les nouveaux crit\u00e8res ne sont pas plus stricts mais plus sp\u00e9cifiques. Ils se [PAGE 1881] fondent sur une s\u00e9rie d'\u00e9tudes sp\u00e9cifiques \u00e0 la question des effets des perturbateurs endocriniens. Ces \u00e9tudes doivent donc \u00eatre r\u00e9alis\u00e9es, puis examin\u00e9es dans le cadre de la proc\u00e9dure de renouvellement de l'admission des substances actives par l'Union europ\u00e9enne. Dans l'Union europ\u00e9enne, un r\u00e9examen de l'admission des substances est pr\u00e9vu tous les quinze ans.</p>\n<p>Comme cela est mentionn\u00e9 dans la r\u00e9ponse \u00e0 la question 21.7801, les autorit\u00e9s suisses ne disposent pas des ressources n\u00e9cessaires pour proc\u00e9der de mani\u00e8re autonome \u00e0 un examen. Nous continuerons donc \u00e0 nous fonder sur les r\u00e9sultats du r\u00e9examen r\u00e9alis\u00e9 par l'Union europ\u00e9enne. Le r\u00e9examen de toutes les substances actives selon les nouveaux crit\u00e8res sera ainsi r\u00e9alis\u00e9 dans une quinzaine d'ann\u00e9es. Rappelons, cependant, que toutes les substances ont d\u00e9j\u00e0 fait l'objet d'un premier examen sur la base des anciens crit\u00e8res.</p>\n</pd_text>","MeetingCouncilAbbreviation":"N","MeetingDate":"20210927","MeetingVerbalixOid":3463,"IdSession":"5111","SpeakerFirstName":"Guy","SpeakerLastName":"Parmelin","SpeakerFullName":"Parmelin Guy","SpeakerFunction":"BPR-M","CouncilId":99,"CouncilName":"Conseil f\u00e9d\u00e9ral","CantonId":22,"CantonName":"Vaud","CantonAbbreviation":"VD","ParlGroupName":null,"ParlGroupAbbreviation":null,"SortOrder":1,"Start":"\/Date(1632754467271)\/","End":"\/Date(1632754529550)\/","Function":"BPR-M","DisplaySpeaker":true,"LanguageOfText":"FR","Modified":"\/Date(1774877009937)\/","StartTimeWithTimezone":"\/Date(1632754467270+0120)\/","EndTimeWithTimezone":"\/Date(1632754529550+0120)\/","VoteBusinessNumber":null,"VoteBusinessShortNumber":null,"VoteBusinessTitle":null}]},"ID":"54322","Language":"FR","IdMeeting":"4520","VerbalixOid":661283,"SortOrder":17,"Modified":"\/Date(1774877009931)\/"}}